Distribuzione geografica
Continente #
NA - Nord America 1824
EU - Europa 360
AF - Africa 68
AS - Asia 28
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2291
Nazione #
US - Stati Uniti d'America 1800
FI - Finlandia 82
NG - Nigeria 68
IT - Italia 62
FR - Francia 48
DE - Germania 45
SE - Svezia 37
CA - Canada 24
NL - Olanda 24
BE - Belgio 22
IE - Irlanda 17
GB - Regno Unito 9
IL - Israele 9
TR - Turchia 6
BR - Brasile 3
CL - Cile 3
IN - India 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CN - Cina 2
IR - Iran 2
RU - Federazione Russa 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
JP - Giappone 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2291
Città #
Wilmington 436
Chandler 388
San Mateo 147
Ann Arbor 128
Helsinki 82
Leawood 82
Lawrence 78
Princeton 78
Benin City 68
Paris 48
Fairfield 38
Woodbridge 38
Boardman 26
Amsterdam 24
Brussels 22
Milan 22
Abbiategrasso 21
Toronto 21
Dublin 17
Seattle 14
Norwalk 10
London 8
San Diego 7
Kocaeli 6
Houston 5
Monmouth Junction 4
Falkenstein 3
Falls Church 3
Giussano 3
Gunzenhausen 3
Alzate Brianza 2
Ashburn 2
Catania 2
Chengdu 2
New York 2
Sacramento 2
San Francisco 2
São Paulo 2
Winnipeg 2
Alexandria 1
Andover 1
Belovo 1
Berlin 1
Bitola 1
Bratislava 1
Brisbane 1
Cambridge 1
Chisinau 1
Clearwater 1
Coimbatore 1
Frankfurt am Main 1
Gazipur 1
Henderson 1
Islamabad 1
Knoxville 1
Kuala Lumpur 1
Las Vegas 1
Lima 1
Montreal 1
Novokuznetsk 1
Prague 1
Saint Paul 1
Tallinn 1
Tel Aviv 1
Tirupur 1
Vienna 1
Zanjan 1
Totale 1876
Nome #
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 53
Colitis-associated cancer: the dark side of inflammatory bowel disease 52
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 52
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 51
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 49
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 48
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 45
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 43
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 43
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 42
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 42
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 41
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study 41
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 41
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 40
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 40
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. 40
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 39
Colitis, microbiota and colon cancer: an infernal triangle 38
Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'? 37
Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis 37
Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation 36
Multiple pathogenic roles of microvasculature in inflammatory bowel disease : a Jack of all trades 36
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 35
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 35
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. 35
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 35
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 34
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 34
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications 33
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 33
OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling 33
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 33
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease 33
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 33
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 33
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 32
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? 32
Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus 32
Antiendomysial antibody detection in fecal supernatants: In vivo proof that small bowel mucosa is the site of antiendomysial antibody production 31
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 30
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE(2) pathway links innate sensing to epithelial homeostasis 30
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 28
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer 28
Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease 28
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 27
Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11 27
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 26
The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind 25
Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled trial 25
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease 24
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer 23
Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions 22
TNF-stimulated gene-6 (TSG-6) is a key regulator in switching stemness and biological properties of mesenchymal stem cells 22
Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6 21
TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells 21
Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 20
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017 20
In vitro Anti-inflammatory and Protective Effects of ibidì® on Intestinal Epithelial Cells 20
Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer 19
Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: A multicentre study 19
The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm 19
Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection 18
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms 18
Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 18
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression 17
Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies 17
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 16
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis 16
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer 15
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 14
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges 13
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel 12
The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease 11
GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity 9
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer 7
The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework 6
Antiendomysial Antibody Detection in Biopsy Culture Allows Avoidance of Gluten Challenge in Celiac Children 6
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine 6
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn’s Disease 4
Forty-Eight Hours of Biopsy Culture Improve the Sensitivity of the in Vitro Gliadin Challenge in the Diagnosis of Celiac Disease 3
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease 3
Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors 3
Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? 3
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial 2
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition 2
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts 1
Totale 2372
Categoria #
all - tutte 12899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12899

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0000 00 00 00032
2020/2021786 91235 4248 11845 16485291
2021/2022457 273878 42 1254 423815732
2022/20231097 1846597118 10785 577 187109630
Totale 2372